Skip Navigation
Skip to contents

J Korean Ophthalmol Soc.  2009 Jan;50(1):135-138. 10.3341/jkos.2009.50.1.135.

The Long-Term Effect of Part-Time Occlusion Therapy According to Compliance in Recurrent Intermittent Exotropia

Affiliations
  • 1Department of Ophthalmology, College of Medicine, Korea University, Seoul, Korea. ansaneye@hanmail.net
  • 2Department of Ophthalmology, Konkuk University College of Medicine, Seoul, Korea.

Abstract

PURPOSE
To evaluate the reoperation rate and the change of exo-angle according to compliance level of part time occlusion therapy in recurrent intermittent exotropia.
METHODS
This retrospective study included 52 patients of recurrent intermittent exotropia who followed up more than 5 years after their first operation. They were ordered part time occlusion therapy for recurrent exotropia. The patients were divided into 4 groups according to the level of compliance of part time occlusion therapy ('excellent', 'good', 'fair', 'poor'). We evaluated the reoperation rate in 5 years after the first operation and the change of exo-angle from the early recurrent time according to compliance levels.
RESULTS
The reoperation rate within 5 years after the first operation of 'excellent' and 'good' compliance groups was lower than that of 'fair' and 'poor' groups (33.3, 26.3, 73.7 and 45.5% respectively) and the degree of exo-angle progression from the early recurrent time of the 'excellent' and 'good' compliance groups was less than that of 'fair' and 'poor' compliance groups, both results of which were statistically significant (p=0.02, 0.03).
CONCLUSIONS
Part time occlusion therapy in recurrent intermittent exotropia has good long-term effects of decreasingreoperation rates in patients with a high level of compliance.

Keyword

Intermittent exotropia; Part time occlusion therapy; Recurrent; Reoperation rate

MeSH Terms

Compliance
Exotropia
Humans
Reoperation
Retrospective Studies
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr